Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
05/28/2026 - 18:42
OTOFARMA
OTOFARMA: THE BOARD OF DIRECTORS APPROVES THE DRAFT FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2025, REVISED THE FINANCIAL CALENDAR AND CALLS THE SHAREHOLDERS' MEETING FOR JUNE 29, 2026 (FIRST CALL)
05/28/2026 - 18:39
OTOFARMA
OTOFARMA: il Consiglio di Amministrazione approva il progetto di bilancio di esercizio e il bilancio consolidato al 31 dicembre 2025, delibera la modifica del calendario e convoca l’Assemblea Ordinaria degli Azionisti per il 29 giugno 2026
04/28/2026 - 08:00
OTOFARMA
OTOFARMA PRESENTA I RISULTATI PRELIMINARI CONSOLIDATI PRO-FORMA AL 31 DICEMBRE 2025: FATTURATO IN CRESCITA DI CIRCA IL 10% E TENUTA DELLA REDDITIVITÀ, GRAZIE AL NETTO MIGLIORAMENTO DELL’EBITDA MARGIN RISPETTO AL PRIMO SEMESTRE 2025
04/28/2026 - 08:00
OTOFARMA
OTOFARMA PRESENTS PRELIMINARY PRO-FORMA CONSOLIDATED RESULTS AS OF DECEMBER 31, 2025: REVENUE UP BY APPROXIMATELY 10% AND STABLE PROFITABILITY, DRIVEN BY A SIGNIFICANT IMPROVEMENT IN EBITDA MARGIN COMPARED TO THE FIRST HALF OF 2025
04/22/2026 - 08:00
OTOFARMA
OTOFARMA: CLOSING COMPLETED FOR THE NEW FACILITY IN MILAN
04/22/2026 - 08:00
OTOFARMA
OTOFARMA: PERFEZIONATO IL CLOSING PER IL NUOVO STABILIMENTO A MILANO
03/24/2026 - 08:00
OTOFARMA
Reorganization of governance and optimization of management structure to boost commercial growth with targeted strategies and planning: Otofarma appoints Gennaro Bartolomucci as new CEO and accelerates the implementation of corporate convergence plan
03/24/2026 - 08:00
OTOFARMA
Riassetto governance e ottimizzazione della struttura manageriale per potenziare crescita commerciale con mirate strategie e progettualità: Otofarma nomina Gennaro Bartolomucci nuovo AD ed accelera l’attuazione del piano di convergenza aziendale
01/28/2026 - 20:00
OTOFARMA
OTOFARMA: 2026 CORPORATE EVENTS CALENDAR
01/28/2026 - 08:04
OTOFARMA
OTOFARMA: CALEDARIO EVENTI SOCIETARI 2026
01/08/2026 - 08:00
OTOFARMA
Otofarma: Nicola Mottola the newly appointed CFO
01/08/2026 - 08:00
OTOFARMA
Otofarma: fa l'ingresso in azienda il nuovo CFO Nicola Mottola
12/22/2025 - 08:15
OTOFARMA
OTOFARMA: SUPERATE LE 700 FARMACIE AFFILIATE NEL 2025
12/22/2025 - 08:15
OTOFARMA
OTOFARMA: OVER 700 AFFILIATED PHARMACIES SURPASSED IN 2025
12/11/2025 - 08:15
OTOFARMA
OTOFARMA AWARDED “BEST IPO 2025” AT THE ASSONEXT AWARDS
12/11/2025 - 08:15
OTOFARMA
OTOFARMA PREMIATA COME BEST IPO 2025 AGLI ASSONEXT AWARDS
10/15/2025 - 08:00
OTOFARMA
OTOFARMA: NEW PLANT IN MILAN TO BOOST PRODUCTION CAPACITY
10/15/2025 - 08:00
OTOFARMA
OTOFARMA: NUOVO STABILIMENTO A MILANO PER RAFFORZARE LA CAPACITÀ PRODUTTIVA
10/01/2025 - 09:18
OTOFARMA
OTOFARMA: BOARD OF DIRECTORS APPROVES HALF-YEAR REPORT AND PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS AS AT 30 JUNE 2025
10/01/2025 - 08:34
OTOFARMA
OTOFARMA: CDA APPROVA LA RELAZIONE SEMESTRALE E I PROSPETTI CONSOLIDATI PRO-FORMA AL 30 GIUGNO 2025
09/08/2025 - 17:49
OTOFARMA
OTOFARMA: announcement of change in share capital following full exercise of greenshoe option
09/08/2025 - 17:47
OTOFARMA
OTOFARMA: comunicazione di avvenuta variazione del capitale sociale a seguito dell’esercizio integrale dell’opzione greenshoe
09/05/2025 - 18:03
OTOFARMA
Internal Dealing
09/02/2025 - 18:17
OTOFARMA
OTOFARMA: full exercise of the Greenshoe Option

Pagination

  • Current page 1
  • Page 2
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are